Kamada (KMDA) Non-Current Debt (2016 - 2023)
Kamada (KMDA) reported Non-Current Debt of $10.7 million for Q2 2023, down 29.27% on a YoY basis from $15.2 million in Q2 2022, and up 90526.05% quarter-over-quarter from $11852.0 in Q1 2023.
Kamada (KMDA) Non-Current Debt (2016 - 2023) Analysis & Trends
Kamada has reported Non-Current Debt for 8 years, with the latest figure at $10.7 million in Q2 2023.
- For the quarter ending Q2 2023, Non-Current Debt fell 29.27% year-over-year to $10.7 million; the trailing twelve-month figure through Jun 2023 stood at $10.7 million (down 29.27% YoY), and the FY2022 full-year result was $13.0 million, down 25.53% from the prior year.
- Non-Current Debt for Q2 2023 stood at $10.7 million, up from $11852.0 in the prior quarter.
- The five-year high for Non-Current Debt was $17.4 million in Q4 2021, with the low at $5000.0 in Q2 2021.
- Historically, Non-Current Debt has averaged $4.4 million across 5 years, with a median of $257000.0 in 2019.
- Annual changes were most pronounced in 2022 — Non-Current Debt surged 303600.0% — and 2023, when it sank 99.93%.
- Kamada's Non-Current Debt stood at $257000.0 in 2019, then plunged by 85.99% to $36000.0 in 2020, then surged by 48252.78% to $17.4 million in 2021, then dropped by 25.53% to $13.0 million in 2022, then dropped by 17.14% to $10.7 million in 2023.
- The last three Non-Current Debt figures came in at $10.7 million (Q2 2023), $11852.0 (Q1 2023), and $13.0 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 10.74 Mn |
| Jun 30, 2023 | 10.74 Mn |
| Mar 31, 2023 | 11,852.00 |
| Mar 31, 2023 | 11,852.00 |
| Dec 31, 2022 | 12.96 Mn |
| Dec 31, 2022 | 12.96 Mn |
| Sep 30, 2022 | 14,074.00 |
| Sep 30, 2022 | 14,074.00 |
| Jun 30, 2022 | 15.19 Mn |
| Jun 30, 2022 | 15.19 Mn |
| Mar 31, 2022 | 16.30 Mn |
| Mar 31, 2022 | 16.30 Mn |
| Dec 31, 2021 | 17.41 Mn |
| Dec 31, 2021 | 17.41 Mn |
| Jun 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 20,000.00 |
| Mar 31, 2021 | 20,000.00 |
| Dec 31, 2020 | 36,000.00 |
| Dec 31, 2020 | 36,000.00 |